Daré Bioscience, Inc. (DARE) Social Stream
DARE BIOSCIENCE INC (DARE) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering DARE BIOSCIENCE INC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-12-08 | 5 | $11 | $3 | $5.4 | $0.309 | 1647.57% |
| 2022-01-19 | 6 | $11 | $3 | $5.5 | $0.309 | 1679.94% |
| 2022-04-01 | 5 | $17 | $3 | $7 | $0.309 | 2165.37% |
| 2022-05-13 | 5 | $17 | $3 | $7.2 | $0.309 | 2230.1% |
| 2022-08-15 | 4 | $6 | $3 | $4.8 | $0.309 | 1453.4% |
| 2022-11-14 | 3 | $6 | $3 | $4.5 | $0.309 | 1356.31% |
| 2022-12-13 | 4 | $7 | $3 | $4.75 | $0.309 | 1437.22% |
| 2023-01-06 | 4 | $7 | $3 | $4.8 | $0.309 | 1453.4% |
| 2023-04-04 | 5 | $8 | $3 | $5.333 | $0.309 | 1625.89% |
| 2023-06-05 | 5 | $8 | $3 | $5.6 | $0.309 | 1712.3% |
| 2023-08-11 | 3 | $8 | $3 | $6 | $0.309 | 1841.75% |
| 2023-09-05 | 3 | $7 | $3 | $5 | $0.309 | 1518.12% |
| 2023-10-20 | 4 | $7 | $2 | $4 | $0.309 | 1194.5% |
| 2023-11-10 | 4 | $6 | $2 | $3.75 | $0.309 | 1113.59% |
The Trend in the Analyst Price Target
Over the past 34 months, DARE's average price target has gone down $1.45.
Over the past 44 weeks, DARE's average upside potential has been 559.1%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-02-14 | 5 | 8 | 3 | 5.333 | 1.140 | 367.81% |
| 2023-04-04 | 5 | 8 | 3 | 5.333 | 1.040 | 412.79% |
| 2023-08-11 | 3 | 8 | 3 | 5.750 | 0.758 | 658.58% |
| 2023-09-05 | 4 | 7 | 2 | 4.666 | 0.660 | 606.97% |
| 2023-10-20 | 4 | 7 | 2 | 4.000 | 0.464 | 762.07% |
DARE Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 4 | 0 | 0 | 0 | 0 | 4 |
The Trend in the Broker Recommendations
DARE's average broker recommendation rating improved by 1 over the prior 34 months.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for DARE as an investment opportunity.
- DARE BIOSCIENCE INC's upside potential (average analyst target price relative to current price) is greater than 2261.76% of all US stocks.
- To contextualize these metrics, consider that out of all US stocks, DARE BIOSCIENCE INC's average analyst price target is higher than 100.15% of them.
- In the context of stocks in the micro market cap category, DARE BIOSCIENCE INC's variance in analysts' estimates is lower than -1916.6% of them.
- In terms of how DARE BIOSCIENCE INC fares relative to Healthcare stocks, note that its number of analysts covering the stock is higher than 446.13% of that group.
Stocks similar to DARE BIOSCIENCE INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are AGRX, PHIO, and ORGS.
View All Top Stocks by Price Target
Is DARE a Buy, Hold or Sell? See the POWR Ratings now!